Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Minneapolis, Minnesota 55454


Purpose:

This study will evaluate the effectiveness of school-based cognitive behavioral therapy with or without parental involvement in treating children with anxiety disorders.


Study summary:

Anxiety disorders are among the most common disorders in children. Although anxiety is a normal part of growing up, the worrying experienced by children with anxiety disorders can persist so far that day-to-day functioning becomes difficult. Physical symptoms of anxiety disorders include a constant sense of worry or stress, headache, nausea, sweating, shaking, and inability to concentrate. Early identification of anxiety disorders is important to prevent progression of the disorder into a chronic issue. Cognitive behavioral therapy (CBT), which focuses on behavioral and thinking modifications, has been shown to be the most effective treatment for anxiety disorders. This study will evaluate the effectiveness of school-based CBT with or without parental involvement in treating children with anxiety disorders, including separation anxiety disorder, generalized anxiety disorder, and social phobia. Participants in this single blind study will be randomly assigned by school to one of three treatment groups: CBT for children only, CBT for children plus parent training, and no treatment control. Each child and parent participant will first undergo an interview, lasting between 1 and 1.5 hours, about the child's symptoms. Additionally, parents will complete forms about their own symptoms. The participants receiving CBT will then attend 9 weekly sessions held in the school buildings after school. In the parental involvement group, parents will attend 9 weekly group training sessions held at the same time as the child's CBT group sessions. During the children's CBT sessions, participants will learn techniques to identify feelings of worry, relax, modify negative thoughts, break down difficult situations into smaller achievable steps, reward themselves for trying hard, and maintain treatment gains. For the parent training group, early sessions will focus on normalizing anxiety during childhood, learning about anxiety, and identifying when their children are feeling anxious. The middle sessions will teach parents the same anxiety management skills being taught to their children and ways to help their children to apply the steps at home. The latter sessions will instruct parents on ways to encourage their children's behaviors in anxiety provoking situations. After completing the 9-week program, participants will attend 2 follow-up booster sessions at Months 1 and 3 post-treatment. Follow-up assessments will occur at Months 3 and 6, possibly at Month 12, and at Years 1, 2, 3, and 4 post-treatment. The assessments will include repeat interviews and forms. At the end of the 6-month follow-up assessment, participants in the no treatment control group will have the opportunity to participate in the CBT group treatment.


Criteria:

Inclusion Criteria: - Total anxiety T-score of greater than 57 on Multidimensional Anxiety Scale for Children and/or teacher nomination as one of the most anxious children in the classroom - Meets DSM-IV criteria for separation anxiety disorder, generalized anxiety disorder, and/or social phobia, or features one or more, but not necessarily all criteria, of one of these disorders with an associated composite CSR of 2 to 6 on ADIS - Both parent and child speak English fluently Exclusion Criteria: - Current diagnosis of the following on ADIS: obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD), conduct disorder, schizophrenia, pervasive developmental disorder (PDD), major depression, bipolar disorder, or substance abuse - Current suicidal or homicidal ideation - Diagnosis of mental retardation (IQ less than 71) on the Kaufman Brief Intelligence Test (KBIT) - Currently receiving psychotropic medication


NCT ID:

NCT00557648


Primary Contact:

Principal Investigator
Gail A. Bernstein, MD
Division of Child and Adolescent Psychiatry, University of Minnesota Medical School


Backup Contact:

N/A


Location Contact:

Minneapolis, Minnesota 55454
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 19, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.